Search clinical trials for: Epoetin

Total 618 results

Watson Pharmaceuticals

Completed

DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin) (DRIVE)

Anemia, Iron-Deficiency | Hemodialysis | Kidney Failure, Chronic

United States
Hoffmann-La Roche

Completed

A Study of Monthly Subcutaneous or Intravenous Mircera in Dialysis Patients With Chronic Renal Anaemia

Anemia

Taiwan
Ahn-Gook Pharmaceuticals Co.,Ltd

Unknown

Investigate a Interaction of Candesartan and Atorvastatin in Healthy Male Sugjects

Healthy Male Subjects

Korea, Republic of
Merck Sharp & Dohme LLC

Terminated

A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease (MK2578-003-AM03-EXT12)

Anemia | Chronic Kidney Disease
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Unknown

Safety & Efficacy of Pegolsihematide for Treatment of Anemia in Participants on Dialysis

Anemia | Dialysis | Chronic Renal Failure

China
Dong-A ST Co., Ltd.

Unknown

To Investigate the Pharmacokinetics of EPORON® and EPREX® After Subcutaneous Administration in Healthy Male Volunteers

Healthy

Korea, Republic of
Hoffmann-La Roche

Completed

An Observational Study of NeoRecormon (Epoetin Beta) in Cancer Patients With Anemia (FAST)

Anemia, Neoplasms

France
Mahidol University

Completed

Cost Utility Analysis of Erythropoietin for Anemia Treatment in Hemodialysis Patients (CUAEPO)

Chronic Renal Failure

Thailand
Hillerod Hospital, Denmark
Aarhus University Hospital; Rigshospitalet, Denmark; Maastricht University Medical... and other collaborators

Completed

Treatment With Erythropoietin and Cognition During Hypoglycaemia

Hypoglycemia | Type 1 Diabetes

Denmark
Medical College of Wisconsin

Withdrawn

Erythropoietin Effects After Traumatic Brain Injury

Traumatic Brain Injury

United States
Federico II University
Friedreich's Ataxia Research Alliance; Associazione Italiana per la lotta alle...

Completed

Efficacy Study of Epoetin Alfa in Friedreich Ataxia (FRIEMAX)

Friedreich Ataxia

Italy
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Observe the Number of Patients Who Develop Pure Red Cell Aplasia (PRCA, a Rare Form of Anemia) While Receiving Epoetin Alfa or Other Recombinant Erythropoietins

Red-Cell Aplasia, Pure
Fundación Pública Andaluza para la gestión de la...

Completed

Efficacy of Ferric Carboxymaltose With or Without EPO Reducing Red-cell Transfusion Packs in Hip Fracture Perioperative Period (PAHFRAC)

Hip Fractures

Spain
Bioven Europe

Terminated

A Randomized Trial to Study the Safety and Efficacy of EGF Cancer Vaccination in Late-stage (IIIB/IV) Non-small Cell Lung Cancer Patients (NSCLC)

Carcinoma, Non-Small-Cell Lung

United Kingdom
Sandoz

Withdrawn

Study to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 in the Treatment of Anemia Associated With Chronic Kidney Disease (SWEEP) (SWEEP)

Anemia | Chronic Renal Insufficiency

Spain, Romania, Bulgaria, France, Germany
University of Alabama at Birmingham

Terminated

The Benefits of a Preoperative Anemia Management Program (PAMP)

Anemia, Iron-Deficiency

United States
Centre Francois Baclesse
Roche Pharma AG; Hospira, now a wholly owned subsidiary of Pfizer; Vifor Pharma

Terminated

Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron Deficiency

Solid Cancer Metastatic Disease | Lymphoid Disease

France
Groupe Francophone des Myelodysplasies

Completed

Treatment of Anemia With Epoetin Beta in Low Risk Myelodysplastic Syndrome (MDS) (EPO-QoL)

Myelodysplastic Syndromes

France
University of Arkansas
National Institutes of Health (NIH); Ortho Biotech Clinical Affairs, L.L.C.

Completed

Effects of Exercise in Combination With Epoetin Alfa

Multiple Myeloma

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Study to Monitor the Incidence of Pure Red Cell Aplasia (PRCA) and/or Antibodies to Erythropoietin Among Participants Receiving Epoetin Alfa or Another Erythropoietin

Red-Cell Aplasia, Pure | Chronic Renal Failure
Shenyang Sunshine Pharmaceutical Co., LTD.

Unknown

rESP Medication With a Single Intravenous Administration and Dose Escalation to Explore the Tolerability ,Safety and Pharmacokinetic Characteristics

Chronic Renal Failure

China
Penang Hospital, Malaysia

Unknown

Effectiveness of a Biosimilar Epoetin Alfa in Stable 'End Stage Renal Failure'

End Stage Renal Failure | Anaemia
University Hospital, Angers

Completed

Use or Non-use of Epoetin Beta in Patients Infected by Chronic Hepatitis C

Chronic Hepatitis C

France
Universitaire Ziekenhuizen KU Leuven

Completed

Combined Drug Approach to Prevent Ischemia-reperfusion Injury During Transplantation of Livers (CAPITL)

Reperfusion Injury

Belgium
Claudia Sue Robertson
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Effects of Erythropoietin on Cerebral Vascular Dysfunction and Anemia in Traumatic Brain Injury

Anemia | Traumatic Brain Injury

United States
Taipei Veterans General Hospital, Taiwan
Taipei City Hospital

Completed

Frequent Dosing of CERA Improves Nutrition and Inflammation in Hemodialysis Patients

Inflammation | Anemia | Malnutrition

Taiwan
Ortho Biotech Products, L.P.

Completed

Dosing and Outcomes Study of Erythropoietic Stimulating Therapies in Patients With Chemotherapy Induced Anemia (DOSE)

Cancer | Anemia
Assistance Publique - Hôpitaux de Paris

Completed

High Dose of Erythropoietin Analogue After Cardiac Arrest (Epo-ACR-02)

Comatose Survivors of Cardiac Arrest

France
Amgen

Completed

TRANSFORM - Observational Cohort Study of Darbepoetin Alfa Use in European Union (EU) Hemodialysis Patients Switched From PEG Epoetin Beta (TRANSFORM)

Anemia

Belgium, France, Netherlands, Greece, Spain, Germany, Switzerland
Johnson & Johnson Pharmaceutical Research & Development...
Ortho Biotech Clinical Affairs, L.L.C.

Terminated

A Study to Investigate the Neuroprotective Effect of PROCRIT (Epoetin Alfa) Versus Placebo in Cancer Patients Who Develop Chemotherapy-induced Peripheral Neuropathy

Peripheral Neuropathy, Chemotherapy-induced

United States
JW Pharmaceutical

Completed

Study of Erythropoietin (EPO) Administration Schedule

Chronic Renal Failure | Anaemia

Korea, Republic of
Janssen-Cilag B.V.

Completed

Cost-effectiveness Study of Epoetin Alfa and Darbepoetin Alfa in Adult Patients With Cancer Who Have Anemia

Neoplasms | Anemia

Netherlands
Johnson & Johnson Pharmaceutical Research & Development...

Completed

An Efficacy and Safety Study of Epoetin Alfa for Initiation and Maintenance Treatment of Patients With Anemia Associated With Chronic Kidney Disease

Anemia

United States, Puerto Rico
Janssen-Cilag Ltd.,Thailand
Mahidol University

Terminated

An Observational Study to Predict the Response of Erythropoietin Treatment in Participants With Cancer Related Anemia Receiving Chemotherapy

Anemia - Cancer Related

Thailand
Janssen-Cilag S.p.A.

Completed

Survey on QUality of Life In myeloDisplasia (SQUID)

Myelodysplastic Syndromes
Johnson & Johnson Pharmaceutical Research & Development...

Completed

PROCRIT Extended Dosing For Maintenance of Hemoglobin in Pre-Dialysis CKD Patients

Anemia | Renal Diseases

United States
Johnson & Johnson Pharmaceutical Research & Development...
Ortho Biotech Products, L.P.

Terminated

Assess Functional Outcomes in Anemic, Critically Ill, Trauma Patients When Taking Epoetin Alfa

Anemia

United States
Amgen

Terminated

Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Patients Receiving Hemodialysis

Anemia

United States
Medgenics Medical Israel Ltd.

Completed

Safety and Efficacy of Sustained Erythropoietin Therapy

Anemia

Israel
University of Florida
Ortho Biotech Clinical Affairs, L.L.C.

Completed

Pilot Study of Epoetin Alfa for Patients Having Abdominal or Pelvic Surgery for Cancer

Anemia

United States
MinYoung Kim, M.D.
LG Life Sciences

Completed

Erythropoietin Therapy for Children With Cerebral Palsy: Phase 1

Cerebral Palsy

Korea, Republic of
PETHEMA Foundation
Roche Pharma AG; Celgene Corporation

Terminated

SIMIDIS: Azacitidine and Beta Erythropoietin Treatment in Patients With Myelodysplastic Syndrome (SIMIDIS)

Myelodysplastic Syndrome

Spain
Forest Laboratories

Completed

Safety, Efficacy, and Tolerability of Vilazodone in Major Depressive Disorder

Major Depressive Disorder

United States
Groupe Francophone des Myelodysplasies
Roche Pharma AG; Celgene Corporation

Completed

Azacitidine Combined to Epoetin Beta in International Prognostic Scoring System (IPSS) Low-risk and Intermediate-1 Myelodysplastic Syndrome (MDS) Patients, Resistant to Erythropoetin-stimulating Agents (ESA)

Myelodysplastic Syndromes

France
Mehrotra, Anita, M.D.
Icahn School of Medicine at Mount Sinai

Terminated

Study of Epoetin Alfa to Treat Anemia After Kidney Transplantation

Anemia

United States
University of Medicine and Dentistry of New Jersey
Ortho Biotech Clinical Affairs, L.L.C.

Terminated

Prevalence and Treatment of Anemia in Rehabilitation Patients

Anemia

United States
Zhengzhou Children's Hospital, China
Zhengzhou University

Completed

Effect of Erythropoietin on Preterm Brain Injury (EPO)

Premature Birth

China
St. Bartholomew's Hospital

Unknown

Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer

Lymphoma | Leukemia | Anemia | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm

United Kingdom
Jinling Hospital, China
Ministry of Health, China

Completed

Oxidative Stress and Inflammation Caused by Intravenous Iron in Crohn's Disease Patients With Iron Deficiency Anemia (CD-AT1)

Crohn's Disease

China
University of Copenhagen
Rigshospitalet, Denmark

Completed

Renal Effects of Erythropoietin in Humans (EPO 2012)

Renal Effects

Denmark

3

Subscribe